DigitalHealth Venture Capital Funding
Healthcare is an industry fraught with challenges and we’re finding that tech can be applied across the 4 P’s – Payers, Providers, Patients, and Pharma. The most important trend we’re seeing in health right now is data explosion. Companies that find ways to capture and analyze high-quality, novel data sets can bring immense value.
Current
NASDAQ: ME
23andMe offers DNA testing with the most comprehensive ancestry breakdown, personalized health insights and more.
23andMe acquired Sierra company Lemonaid Health
Exited
NASDAQ: AMGP
Currently serving more than 2.7 million members in 13 states nationwide, Amerigroup offers solutions that improve health care access and quality for members. Amerigroup manages publicly funded health programs.
Exited
TEAM MEMBER: TIM GULERI
Acquired by Roche
Bina is a leader in the genome sequencing space, and is led by a Stanford PhD. The company’s Bina Box appliance is making genome analysis faster than ever, and accessible to those without supercomputers.
Current
TEAM MEMBER: VIGNESH RAVIKUMAR
Decoded Health is developing the world's first Clinical Hyperautomation Platform, leveraging explainable machine learning with Human-In-the-Loop Task Autonomy.
Exited
Exited
NASDAQ: HLTH
Healtheon develops and markets Internet-based on-line health care and benefit information and services.
Exited
Intuitive Surgical is the global leader in the rapidly emerging field of robotic-assisted minimally invasive surgery. Since its inception, the company has consistently provided surgeons and hospitals with the tools needed to improve clinical outcomes and to help patients return to active lives.
Current
Exited
Acquired by 23andMe
Lemonaid Health is a national online doctor's office. Our services are provided by one of our four medical groups.
Current
TEAM MEMBER: MARK FERNANDES
A modern and comprehensive health insurance plan for employees in India.
Current
TEAM MEMBER: Vignesh Ravikumar
Pluto Health is bridging siloed health data with patient care. We aim to address gaps in care all while having strong convictions for patient privacy and data ownership.
Current
TEAM MEMBER: MARK FERNANDES
Reify Health is the leading platform for patient enrollment for clinical trials.
In 2022 Reify raised a $220 Series D at a $4.8 Billion valuation.
Exited
NASDAQ: THRX
Theravance is a biopharmaceutical company with a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies.
There are no results.